The three human monocyte subsets: implications for health and disease

KL Wong, WH Yeap, JJY Tai, SM Ong, TM Dang… - Immunologic …, 2012 - Springer
Human blood monocytes are heterogeneous and conventionally subdivided into two
subsets based on CD16 expression. Recently, the official nomenclature subdivides …

T cell responses in the central nervous system

T Korn, A Kallies - Nature Reviews Immunology, 2017 - nature.com
T cells are required for immune surveillance of the central nervous system (CNS); however,
they can also induce severe immunopathology in the context of both viral infections and …

Human immunodeficiency virus‐associated neurocognitive disorders: mind the gap

JC McArthur, J Steiner, N Sacktor, A Nath - Annals of neurology, 2010 - Wiley Online Library
Human immunodeficiency virus (HIV)‐associated neurocognitive disorders (HANDs) remain
among the most common disorders in people infected with HIV, even in an era when potent …

Chronic exposure to a TLR ligand injures hematopoietic stem cells

BL Esplin, T Shimazu, RS Welner… - The Journal of …, 2011 - journals.aai.org
Hematopoietic stem cells (HSC) can be harmed by disease, chemotherapy, radiation, and
normal aging. We show in this study that damage also occurs in mice repeatedly treated with …

Illuminating viral infections in the nervous system

DB McGavern, SS Kang - Nature Reviews Immunology, 2011 - nature.com
Viral infections are a major cause of human disease. Although most viruses replicate in
peripheral tissues, some have developed unique strategies to move into the nervous …

Targeting CCR5 as a component of an HIV-1 therapeutic strategy

H Mohamed, T Gurrola, R Berman, M Collins… - Frontiers in …, 2022 - frontiersin.org
Globally, human immunodeficiency virus type 1 (HIV-1) infection is a major health burden for
which successful therapeutic options are still being investigated. Challenges facing current …

Pathogenesis of HIV in the central nervous system

V Valcour, P Sithinamsuwan, S Letendre… - Current Hiv/aids …, 2011 - Springer
HIV can infect the brain and impair central nervous system (CNS) function. Combination
antiretroviral therapy (cART) has not eradicated CNS complications. HIV-associated …

Barriers for HIV cure: the latent reservoir

S Castro-Gonzalez, M Colomer-Lluch… - AIDS research and …, 2018 - liebertpub.com
Thirty-five years after the identification of HIV-1 as the causative agent of AIDS, we are still in
search of vaccines and treatments to eradicate this devastating infectious disease. Progress …

HIV interactions with monocytes and dendritic cells: viral latency and reservoirs

CM Coleman, L Wu - Retrovirology, 2009 - Springer
HIV is a devastating human pathogen that causes serious immunological diseases in
humans around the world. The virus is able to remain latent in an infected host for many …

Incomplete immune recovery in HIV infection: mechanisms, relevance for clinical care, and possible solutions

JC Gaardbo, HJ Hartling, J Gerstoft… - Journal of Immunology …, 2012 - Wiley Online Library
Treatment of HIV‐infected patients with highly active antiretroviral therapy (HAART) usually
results in diminished viral replication, increasing CD4+ cell counts, a reversal of most …